Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-07

Clinical Trial Update: A Non-interventional Study Investigating Semaglutide in Combination With Lifestyle-based Modifications for the Management of Obesity in Real-World Clinical Practice in Germany (WeGo Real Germany).

View source ↗

Summary

A non-interventional, real-world study in Germany evaluating the use of semaglutide with lifestyle changes for obesity management. The study is enrolling by inv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Status: ENROLLING_BY_INVITATION